Ultralife (NASDAQ:ULBI) issued its quarterly earnings data on Thursday. The technology company reported $0.03 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The business had revenue of $18.88 million for the quarter. Ultralife had a return on equity of 27.92% and a net margin of 28.59%.
ULBI traded up $0.07 during trading on Friday, reaching $9.07. 42,851 shares of the company were exchanged, compared to its average volume of 53,951. The stock has a market capitalization of $181.75 million, a price-to-earnings ratio of 7.55 and a beta of 0.60. Ultralife has a 12-month low of $6.30 and a 12-month high of $11.97.
Separately, ValuEngine raised Ultralife from a “hold” rating to a “buy” rating in a report on Wednesday, February 13th.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Barclays PLC lifted its holdings in Ultralife by 153.5% during the 4th quarter. Barclays PLC now owns 11,433 shares of the technology company’s stock worth $77,000 after purchasing an additional 6,923 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Ultralife by 1.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,060,836 shares of the technology company’s stock valued at $7,161,000 after acquiring an additional 10,628 shares in the last quarter. Renaissance Technologies LLC raised its holdings in shares of Ultralife by 4.4% in the 3rd quarter. Renaissance Technologies LLC now owns 258,100 shares of the technology company’s stock valued at $2,104,000 after acquiring an additional 10,834 shares in the last quarter. Alambic Investment Management L.P. purchased a new stake in shares of Ultralife in the 4th quarter valued at about $141,000. Finally, Teton Advisors Inc. raised its holdings in shares of Ultralife by 37.1% in the 1st quarter. Teton Advisors Inc. now owns 81,300 shares of the technology company’s stock valued at $835,000 after acquiring an additional 22,000 shares in the last quarter. 30.82% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Ultralife (ULBI) Issues Earnings Results” was reported by Zolmax and is the property of of Zolmax. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://zolmax.com/investing/ultralife-ulbi-issues-earnings-results-2/3069753.html.
Ultralife Company Profile
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Story: Cost of equity and a company’s balance sheet
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.